Metabolix announces Jay Kouba, Ph.D., chairman of the board, will assume the role of president and CEO. Dr. Kouba replaces James J. Barber, Ph.D., who resigned as president, CEO and as a member of the board of directors.
Ian Garland joins Acambis as its new CEO.
James Green is selected as the next president and CEO of Analogic Corporation. Prior to joining Analogic, Green was regional vice president for Quest Diagnostics.
Aspreva Pharmaceuticals announced that CEO and chairman Richard Glickman is retiring for personal reasons.
Xcellerex names Joseph Zakrzewski CEO and a member of the company's board of directors.
BioServe names Kevin Krenitsky, M.D. as CEO.
Dyax announces the resignation of Thomas Beck, M.D., as the company's president and COO. Dr. Beck will remain with the company in a consulting capacity.
CytoCore appoints Richard Domanik, PhD, as its new president.
Rosetta Genomics names J. Michael French as the new president of its U.S. subsidiary.
Avalon Pharmaceuticals announces C. Eric Winzer will become the company's new CFO, succeeding Gary Lessing.
MediGene announces CFO Alexander Dexne has left the company.
ProEthic Pharmaceuticals names James R. Lattanzi as the company's CFO.
Pharmacyclics names Michael K. Inouye as senior vice president of corporate and commercial development.
China Biopharmaceuticals Holdings announces Zhang Jian has been elected chairwoman of the board of directors, Shi Mingsheng has been named COO, and Ding Weihua has been appointed to the board of directors.
Favrille appoints Richard Ghalie, M.D., as chief medical officer.
Velcura Therapeutics names Bill Cadwallader executive vice president of corporate development.
PAREXEL International appoints Joe Avellone, M.D. to vice president of operations for clinical research services, Americas.
Marshall G. Cox resigns from Cytori Therapeutics' board of directors.
Dr. Marilyn Barrett signs on as a scientific advisor with Next Pharmaceuticals.
Array BioPharma names Jonathan Kay, M.D., to its Scientific Advisory Board.
IGI announces Subhash Saxena, Ph.D., has been retained as a technical consultant and will serve on the Scientific Advisory Board.
ARIUS Research announces Joseph Zakrzewski has been appointed to the company's board of directors.
Esprit Pharma elects Robert E. Baldini to its board of directors.
DOV Pharmaceutical elects Joseph S. Zakrzewski to its board.
Inovio Biomedical elects Bob Rieder to its board.
Valeant Pharmaceuticals International elects G. Mason Morfit to its board of directors.
Leonard S. Jacob, M.D., Ph.D., resigns as a director and its non-executive chairman of the board of Bradley Pharmaceuticals.
Dr. Joshua Boger, chairman, president and CEO of Vertex Pharmaceuticals, was elected chair of the board of BIO, succeeding James C. Mullen, president and CEO of Biogen Idec.